Loading clinical trials...
Loading clinical trials...
Evaluation of Quality of Life in Patients After Placement of a Modified Double J Ureteral Stent. Randomized Clinical Trial.
Double-J (DJ) stents are commonly inserted after ureteroscopy. There are several complications associated with the presence of DJ stent: urinary tract infection, stent encrustation, stent migration, and stent-related symptoms (SRS). SRS occur in up to 80% of patients and include pain, hematuria, and dysuria, all of which negatively impact the patient's quality of life. Physicians proposed the distal end of the ureteral stents might involve in SRS by over-simulating the trigone of bladder. The design of the distal end, made with a thinner loop than that of a standard DJ stent, is intended to mitigate SRS and reduce urine reflux.
Study Design: Prospective, randomized, open-label, controlled trial with two parallel arms. Study Center: Department of Urology, St. Luke's Clinical Hospital, St. Petersburg, Russia Study Population: All patients should not be prestented and should have no ureteral obstruction. 40 patients, divided into four equal groups of 20 people each: Group I (standard DJ stent): Group II (modified DJ stent) Procedure for evaluation: After surgery ( RIRS, ureteroscopy) reflux is assessed (gravity-filling cystogram). After stenting, the presence of post-stent reflux is assessed. In the postoperative period, patients complete the USSQ (1st day, 7th day and before stent removal). Statistics method: The results are presented as the median and interquartile range (IQR) for continuous variables, and as frequencies (n with percentage %) for categorical variables. Statistical comparisons of all primary and secondary outcome measures between different treatment groups were conducted using the Mann-Whitney U test for continuous data. Meanwhile, categorical variables were analyzed using either Pearson's chi-square (χ²) test or Fisher's exact test, where appropriate. Thenthreshold for statistical significance was established at 5%, implying that a p-value less than 0.05 (p \< 0.05) was considered statistically significant for all tests performed.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
St. Luke's Clinical Hospital
Saint Petersburg, Outside U.S./Canada, Russia
Start Date
December 28, 2025
Primary Completion Date
April 1, 2026
Completion Date
April 1, 2026
Last Updated
December 10, 2025
40
ESTIMATED participants
Ureteric stent insertion
PROCEDURE
Lead Sponsor
St. Luke's Clinical Hospital, Russia
NCT07444697
NCT06819592
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions